NEVRO CORP

Profile

Company Names

NEVRO CORP

Addresses

4040 CAMPBELL AVENUE, SUITE 210, MENLO PARK, CA 94025

411 ACACIA AVENUE, PALO ALTO, CA 94306

Phone Numbers

650-251-0005

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER

Year Incorporated:

2006

State Incorporated:

DELAWARE

Total Amount Raised:

$78,604,690.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2011-07-15 
$58,604,692.00 
$58,604,692.00 
$0.00 
Equity 
1
2010-03-08 
$19,999,998.00 
$21,003,318.00 
$1,003,320.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KONSTANTINOS 
 
ALATARIS 
EXECUTIVE OFFICER, DIRECTOR
NEVRO CORP   |  ZOSANO PHARMA CORP   |  INVICTA MEDICAL, INC.
JOHN 
 
DEEDRICK 
DIRECTOR
TORAX MEDICAL INC   |  NEVRO CORP   |  MYOSCIENCE INC   |  LINN GROVE GROWTH FUND I, LP   |  CANOPY CO.   |  BACTERIN INTERNATIONAL HOLDINGS, INC.   |  ACTIVORTHO, INC.   |  DYAMX, INC.   |  SUBIOMED, INC.   |  ENDOGENEX, INC.
MICHAEL 
 
DEMANE 
EXECUTIVE OFFICER, DIRECTOR
DENALI MEDICAL INC   |  ROTATION MEDICAL INC   |  DENALI MEDICAL II, INC.   |  TORAX MEDICAL INC   |  NEVRO CORP   |  CARDIONOMIC, INC.   |  SYNAPTIVE MEDICAL INC.
ANDREW 
 
GALLIGAN 
EXECUTIVE OFFICER
OOMA INC   |  NEVRO CORP   |  CELLSCAPE CORP
BILL 
 
HARRINGTON 
DIRECTOR
NEVRO CORP   |  RUNA, LLC   |  MICROTRANSPONDER, INC.
VINCE 
 
KIM 
DIRECTOR
NEOSTIM INC   |  NEVRO CORP   |  CERVEL NEUROTECH, INC.
VINCENT 
 
KIM 
DIRECTOR
NEVRO CORP   |  POSIT SCIENCE CORP   |  CERVEL NEUROTECH, INC.   |  CRICKET HEALTH, INC.
MARK 
 
KNUDSON 
DIRECTOR
NEVRO CORP
MARK 
B. 
KNUDSON 
DIRECTOR
NEVRO CORP
BILL 
 
MOFFITT 
DIRECTOR
NEVRO CORP
NATHAN 
 
PLIAM 
DIRECTOR
NEVRO CORP
NICK 
 
PLIAM 
DIRECTOR
NEVRO CORP   |  MEDICAL CREATIONS, INC.
JON 
 
TREMMEL 
DIRECTOR
INSET TECHNOLOGIES INC   |  NEVRO CORP   |  FLOWONIX MEDICAL INC   |  RESHAPE LIFESCIENCES INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2011-07-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-07-15 
2010-04-23
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-08 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#